Novel compounds of the formula I in which X, Y, Z, R, R
1
, R
2
and R
3
are as defined in Patent claim
1
, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of tromboembolic diseases and for the treatment of tumours
1
公式I中的化合物,其中X、Y、Z、R、R1、R2和R3如专利权要求书1中所定义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓性疾病和肿瘤的治疗。